Inventaire - i tuoi amici e le tue comunità sono la tua biblioteca

RET fusion gene: translation to personalized lung cancer therapy

autore

Kiyotaka Yoh

Katsuya Tsuchihara

Takashi Kohno

pubblicato in: Cancer Science

data di pubblicazione: 2013-10-01

argomento principale: carcinoma del polmone

Cita articoli 31

Data

Titolo

Autori

2013-06-01

Acquired resistance to crizotinib from a mutation in CD74-ROS1

Ryohei Katayama, Luc Friboulet, Mari Mino-Kenudson, A John Iafrate, Jeffrey A Engelman, Keith D Wilner, Alice T Shaw, James G Christensen
2013-04-22

Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives

Julien Mazieres, Benoit Lepage, Alexis B Cortot, Helene Blons, Denis Moro-Sibilot, Christos Chouaid, Marie Wislez, Enriqueta Felip, Oliver P Gautschi
2013-04-15

Personalizing oncology: perspectives and prospects
2013-05

A patient with lung adenocarcinoma and RET fusion treated with vandetanib

Oliver P Gautschi
2013-05-12

Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo

Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto, Katsuya Tsuchihara, Hiroyasu Esumi, Sachiyo Mimaki, Takashi Kohno, Atsushi Ochiai, Genichiro Ishii, Tatsuhiro Shibata, Koji Tsuta, Hideki Makinoshima
2013-03-26

Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas

Marc Ladanyi
2013-03-06

RET inhibition: implications in cancer therapy

Marco A. Pierotti, Laura D. Locati, Angela Greco, Lisa Licitra
2013-02-06

A high-dimensional, deep-sequencing study of lung adenocarcinoma in female never-smokers

Wan Kyu Kim, Namshin Kim
2013-02-11

New targetable oncogenes in non-small-cell lung cancer

Pasi A Jänne
2013-02-11

ALK in lung cancer: past, present, and future
2013-04-01

ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases

Hitoshi Tsuda, Takashi Kohno, Tatsuhiro Shibata, H. Asamura
2013-02-01

KIF5B-RET fusions in Chinese patients with non-small cell lung cancer
2012-12-01

Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad

Hiroyuki Aburatani
2012-10-10

Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions

Marc Ladanyi, Mark G. Kris, Valerie W Rusch
2012-09-14

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing

Eric Lander, Kristian Cibulskis, Daniel Auclair, Gad Getz, Wendy Winckler, Eran Hodis, Carrie Sougnez, Heidi Greulich, Marcin Imielinski, Petar Stojanov, Danila Seidel, Trevor J Pugh, Harvey I Pass, Marzia Capelletti, William Pao, Matthew Meyerson, Stacey Gabriel, Pasi A Jänne, Levi A Garraway, Andrey Sivachenko
2012-06-06

Vandetanib for the treatment of lung cancer
2012-05-21

ALKoma: a cancer subtype with a shared target
2012-05-11

Quality of life with gefitinib in patients with EGFR-mutated non-small cell lung cancer: quality of life analysis of North East Japan Study Group 002 Trial
2012-02-12

KIF5B-RET fusions in lung adenocarcinoma

Hirokazu Okayama, Yasuhito Arai, Hitoshi Tsuda, Takashi Kohno, Tatsuhiro Shibata, Yasushi Totoki
2012-02-12

RET, ROS1 and ALK fusions in lung cancer
2012-03-06

Chipping away at the lung cancer genome.

William Pao
2012-02-12

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

Pasi A Jänne
2012-11-13

RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer.

William Pao
2012-02-21

Identification of RET gene fusion by exon array analyses in "pan-negative" lung cancer from never smokers
2012-10-01

A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.

Oliver P Gautschi
2012-07-13

KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung.
2011-12-22

A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing

Young Seok Ju, Thomas Bleazard, Jae-Kyung Won
2011-08-23

Multikinase inhibitors: a new option for the treatment of thyroid cancer

Roderick J Clifton-Bligh, Bruce Robinson
2011-05-17

CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant
2010

Cancer statistics, 2010
2010-06-24

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Articolo - wd:Q33711282

Benvenuto su Inventaire

la biblioteca dei tuoi amici e della tua comunità

ulteriori informazioni